David Skurnik
Overview
Explore the profile of David Skurnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
3267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reisacher C, Saifi E, Ageron E, Mallmann R, Klugbauer N, Skurnik D, et al.
Mol Microbiol
. 2025 Feb;
PMID: 39992886
MicroRNAs have recently emerged as major players in host -bacterial pathogen interactions, either as part of the host defense mechanism to neutralize infection or as a bacterial arsenal aimed at...
2.
Mammeri H, Sereme Y, Toumi E, Faury H, Skurnik D
PLoS Pathog
. 2025 Feb;
21(2):e1012902.
PMID: 39919103
The increasing resistance of Gram-negative bacteria to last resort antibiotics, such as carbapenems, is particularly of concern as it is a significant cause of global health threat. In this context,...
3.
Sereme Y, Faury H, Gravrand V, Ageron E, Poyart C, Skurnik D, et al.
Antimicrob Agents Chemother
. 2024 Sep;
68(11):e0103624.
PMID: 39315804
The fitness cost associated with antimicrobial resistance has an important influence on evolutionary dynamics. We compared the genomes of three isolates recovered from blood samples or deep abscess cultures from...
4.
Xiang Y, Mata-Garrido J, Fu Y, Desterke C, Batsche E, Hamai A, et al.
EMBO Mol Med
. 2024 Sep;
16(10):2652.
PMID: 39284950
No abstract available.
5.
Kramarska E, Toumi E, Squeglia F, Laverde D, Napolitano V, Frapy E, et al.
NPJ Vaccines
. 2024 Aug;
9(1):151.
PMID: 39155280
ESKAPE pathogens are responsible for complicated nosocomial infections worldwide and are often resistant to commonly used antibiotics in clinical settings. Among ESKAPE, vancomycin-resistant Enterococcus faecium (VREfm) and methicillin-resistant Staphylococcus aureus...
6.
Xiang Y, Mata-Garrido J, Fu Y, Desterke C, Batsche E, Hamai A, et al.
EMBO Mol Med
. 2024 Apr;
16(6):1404-1426.
PMID: 38684864
As an important immune stimulator and modulator, IFNγ is crucial for gut homeostasis and its dysregulation links to diverse colon pathologies, such as colitis and colorectal cancer (CRC). Here, we...
7.
Sereme Y, Schrimp C, Faury H, Agapoff M, Lefebvre-Wloszczowski E, Chang Marchand Y, et al.
Nat Commun
. 2024 Apr;
15(1):3021.
PMID: 38589401
Preterm birth is currently the leading cause of neonatal morbidity and mortality. Genetic, immunological and infectious causes are suspected. Preterm infants have a higher risk of severe bacterial neonatal infections,...
8.
Sereme Y, Toumi E, Saifi E, Faury H, Skurnik D
Cell Immunol
. 2023 Dec;
395-396:104796.
PMID: 38104514
Newborns, whether born prematurely or at term, have a fully formed but naive immune system that must adapt to the extra-uterine environment to prevent infections. Maternal immunity, transmitted through the...
9.
Moulin D, Millard M, Taieb M, Michaudel C, Aucouturier A, Lefevre A, et al.
Ann Rheum Dis
. 2023 Dec;
83(3):312-323.
PMID: 38049981
Objectives: Alterations in tryptophan (Trp) metabolism have been reported in inflammatory diseases, including rheumatoid arthritis (RA). However, understanding whether these alterations participate in RA development and can be considered putative...
10.
Johnson K, Delaney J, Guillard T, Reffuveille F, Varin-Simon J, Li K, et al.
PLoS Pathog
. 2023 Sep;
19(9):e1011612.
PMID: 37676873
The increase in emerging drug resistant Gram-negative bacterial infections is a global concern. In addition, there is growing recognition that compromising the microbiota through the use of broad-spectrum antibiotics can...